Related Experiment Video
Updated: May 28, 2026

Isolation of Glomeruli and In Vivo Labeling of Glomerular Cell Surface Proteins
Published on: January 18, 2019
Contrast-Induced Nephropathy
Masaru Nemoto1, Sohei Matsuura1, Yusuke Sakurai1
1Department of Vascular Surgery, Fujita Health University, Toyoake, Aichi, Japan.
Insights
Contrast-induced nephropathy (CIN) is a risk in patients undergoing cardiovascular procedures with iodinated contrast media. Identifying risk factors and using preventive measures like hydration can mitigate CIN development and improve patient outcomes.
Area of Science:
- Nephrology
- Radiology
- Cardiovascular Medicine
Background:
- Cardiovascular disease diagnosis and treatment frequently utilize iodinated contrast media.
- Renal dysfunction poses a challenge due to the risk of contrast-induced nephropathy (CIN).
- CIN can result from direct tubular cell injury and medullary ischemia induced by contrast agents.
Purpose of the Study:
- To review the risk factors and prevention strategies for contrast-induced nephropathy (CIN).
- To highlight the importance of risk assessment before administering contrast media.
- To discuss the differences in risk between intravenous and intra-arterial contrast administration.
Main Methods:
- Review of existing literature on contrast-induced nephropathy.
- Identification of patient risk factors for CIN, including chronic kidney disease, advanced age, and diabetes mellitus.
- Analysis of risk differences between intravenous and intra-arterial contrast administration routes.
Main Results:
- While CIN frequency may be lower than previously thought, it has no effective treatment and can impact mortality.
- Key risk factors for CIN include chronic kidney disease, advanced age, and diabetes mellitus.
- Intra-arterial administration carries a different risk profile compared to intravenous administration.
Conclusions:
- Pre-procedure risk assessment for CIN is crucial in patients undergoing contrast-enhanced imaging.
- Preventive measures such as intravenous saline or sodium bicarbonate hydration may reduce CIN incidence.
- Minimizing contrast media volume within recommended ranges is advised for at-risk patients.
Abstract:
Diagnosis and treatment of cardiovascular diseases often require the administration of iodinated contrast media. However, it is sometimes difficult to use such contrast media in patients with renal dysfunction because direct mechanisms of tubular cell injury and indirect mechanisms of medullary ischemia, together with the contrast medium, may cause contrast-induced nephropathy (CIN). Although the frequency of developing CIN is said to be lower than previously estimated, once it develops, there is no effective treatment, and it may affect mortality. Therefore, before using a contrast medium, it is necessary to identify the risk factors of CIN in patients-including chronic kidney disease, advanced age, and diabetes mellitus-and understand the risk differences between intravenous and intra-arterial contrast medium administration. If there is any risk, intravenous saline or sodium bicarbonate treatments may be used to prevent CIN onset, and the use of minimum amounts of contrast media, within the corresponding range, may be recommended. (This is a translation of Jpn J Vasc Surg 2024; 33: 143-147.).
Related Concept Videos
Cardiac Catheterization I: Pre-Procedure Overview
Continuous Renal Replacement Therapy
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology
